EIGHTH SUPPLEMENTAL INDENTUREEighth Supplemental Indenture • November 22nd, 2022 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
This Eighth Supplemental Indenture (this “Supplemental Indenture”), is entered into as of November 21, 2022, among Quotient Limited, a public limited liability no par value company formed under the laws of Jersey, Channel Islands (the “Issuer”), the Guarantors party hereto, and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
